Abiopharma

New Form 10-Q - PTC THERAPEUTICS, INC. Filed: 2025-08-07 AccNo: 0001558370-25-010796 Size: 14 MB

New Form 4 - ESSA Pharma Inc. Filed: 2025-08-07 AccNo: 0000921895-25-002133 Size: 38 KB

Xbox Cloud Gaming in August 2025: Complete Guide

New Form 10-Q - Atea Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-105123 Size: 9 MB

New Form SCHEDULE 13G/A - ANAPTYSBIO, INC Filed: 2025-08-07 AccNo: 0001999371-25-010859 Size: 13 KB

New Form 10-Q - SANUWAVE Health, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038937 Size: 6 MB

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

New Form 8-K - Elicio Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001601485-25-000108 Size: 1 MB Item 2.02: Results of Operations and Financial Condition

New Form DEFA14A - Canopy Growth Corp Filed: 2025-08-07 AccNo: 0001104659-25-075221 Size: 532 KB

New Form 3 - Inogen Inc Filed: 2025-08-07 AccNo: 0000950170-25-105116 Size: 14 KB

New Form 8-K - PUMA BIOTECHNOLOGY, INC. Filed: 2025-08-07 AccNo: 0001437749-25-025463 Size: 412 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

A New Press Release from Elicio Therapeutics

New Form 8-K - AVITA Medical, Inc. Filed: 2025-08-07 AccNo: 0001762303-25-000012 Size: 781 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form ARS - Canopy Growth Corp Filed: 2025-08-07 AccNo: 0001104659-25-075218 Size: 11 MB

New Form 3 - Inogen Inc Filed: 2025-08-07 AccNo: 0000950170-25-105112 Size: 14 KB